This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 31 December 2023-6 January 2024 and includes updates on Avian influenza A(H5N6 and H9N2), SARS-CoV-2 variant classification, Western Equine Encephalitis, and an overview of respiratory virus epidemiology in the EU/EEA.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 17-23 December 2023 and includes updates on cholera, SARS-CoV-2 variant classification, avian influenza in fur farms, hepatitis A, pertussis, a cluster of extensively drug-resistant Shigella Sonnei among men who have sex with men, and an overview of respiratory virus epidemiology in the EU/EE.
Sixty cases of diphtheria due to toxigenic Corynebacterium diphtheriae (n=29) or C. ulcerans (n=31), and one case with unknown pathogen were reported to ECDC in 2021.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 10-16 December 2023 and includes updates on measles, chikungunya, dengue, SARS-CoV-2, diphtheria, West Nile virus, respiratory virus epidemiology and influenza.
ECDC initiated a survey of EU/EEA countries to evaluate preparedness planning and risk mitigation initiatives implemented at the country level for people exposed to highly pathogenic avian influenza virus A(H5N1).
This protocol sets out measures for the follow-up and management of individuals exposed to infected animals and human cases of avian influenza, and for the public health management of possible and confirmed human cases.
The aim of this survey was to review the expertise, capabilities and capacities for detection and characterisation of avian and other zoonotic influenza viruses in national influenza reference laboratories in the European Union/European Economic Area (EU/EEA), in members of the European Reference Laboratories for influenza (ERLINet), and in EU Enlargement policy countries.
This scientific report provides an overview of highly pathogenic avian influenza (HPAI) virus detections in poultry, captive birds, wild birds, and mammals that occurred in and outside Europe between 2 September and 1 December 2023, as well as human cases due to avian influenza viruses up until 1 December 2023.